Non-small cell lung cancer: stereoxatic radiotherapy, patient survival and nursig performance
DOI:
https://doi.org/10.5281/zenodo.7319609Keywords:
Mortality, Radiation Oncology, Lung Neoplasms.Abstract
Objective: To evaluate patients who work with stereotactic body radiotherapy (SBRT) in patients who have an initial and operational stage, toxicity dosages and survival of this information to this treatment. Methods: This is an integrative review of the descriptive literature from 2017 to 2022, through an investigation in the electronic database of the Virtual Health Library (BVS - BIREME). Results: Nine scientific articles were selected. They are themes that were chosen to address the themes defined by them, thus making an association with them with the proposed proposal to obtain a set of parameters and an adjusted class among the authors. Final Considerations: The study contemplated an evaluation of SBRT) body stereotactic pulse treatment as a therapy being more incidental for inoperable non-small cell cancer cases and with a higher survival rate. being small doses.
Downloads
References
Tortora GJ, Nielsen MT. Princípios de anatomia humana. Rio de Janeiro: Guanabara Koogan, 2013. 1114 p.
Instituto Nacional de Câncer – INCA. O que é câncer? Disponível em: https://www.gov.br/inca/pt-br/assuntos/cancer/o-que-e-cancer/
Brey, C., Gouveia, F. T., Silva, B. S., Sarquis, L. M. M., Miranda, F. M. D., & Consonni, D. (2020). Lung cancer related to occupational exposure: An integrative review. Revista Gaúcha de Enfermagem, 41, e20190378.
Jiang, Y., Zhang, L., Zhu, F., Zhu, H., Cao, X., & Zhang, Y. (2022). Camrelizumab combined with anlotinib for the treatment of small cell lung cancer: A case report and literature review. Annals of Palliative Medicine, 11(3), 1135–1146. https://doi.org/10.21037/apm-21-3860
Liu, B., Zhou, F., Liu, H., Wang, Y., Wang, J., Ren, F., & Xu, S. (2022). Knockdown of LINC00511 decreased cisplatin resistance in non-small cell lung cancer by elevating miR-625 level to suppress the expression of leucine rich repeat containing eight volume-regulated anion channel subunit E. Human & Experimental Toxicology, 41, 096032712210890.
Martins, O., & Azevedo, I. (2020). Radioterapia paliativa para cuidados oncológicos em fim de vida. Medicina Interna, 27(1), 49–54.
Inoue, T., Katoh, N., Ito, Y. M., Kimura, T., Nagata, Y., Kuriyama, K., Onishi, H., Yoshitake, T., Shioyama, Y., Iizuka, Y., Inaba, K., Konishi, K., Kokubo, M., Karasawa, K., Kozuka, T., Tanaka, K., Sakakibara-Konishi, J., Kinoshita, I., & Shirato, H. (2018). Stereotactic body radiotherapy to treat small lung lesions clinically diagnosed as primary lung cancer by radiological examination: A prospective observational study. Lung Cancer, 122, 107–112.
Videtic, G. M., Paulus, R., Singh, A. K., Chang, J. Y., Parker, W., Olivier, K. R., Timmerman, R. D., Komaki, R. R., Urbanic, J. J., Stephans, K. L., Yom, S. S., Robinson, C. G., Belani, C. P., Iyengar, P., Ajlouni, M. I., Gopaul, D. D., Gomez Suescun, J. B., McGarry, R. C., Choy, H., & Bradley, J. D. (2019). Long-term follow-up on nrg oncology rtog 0915 (Ncctg n0927): A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage i peripheral non-small cell lung cancer. International Journal of Radiation Oncology*Biology*Physics, 103(5), 1077–1084.
Onimaru, R., Onishi, H., Ogawa, G., Hiraoka, M., Ishikura, S., Karasawa, K., Matsuo, Y., Kokubo, M., Shioyama, Y., Matsushita, H., Ito, Y., & Shirato, H. (2018). Final report of survival and late toxicities in the Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (Jcog0702). Japanese Journal of Clinical Oncology, 48(12), 1076–1082.
Singh, A. K., Gomez-Suescun, J. A., Stephans, K. L., Bogart, J. A., Hermann, G. M., Tian, L., Groman, A., & Videtic, G. M. (2019). One versus three fractions of stereotactic body radiation therapy for peripheral stage i to ii non-small cell lung cancer: A randomized, multi-institution, phase 2 trial. International Journal of Radiation Oncology*Biology*Physics, 105(4), 752–759.
Steber CR, Hughes RT, Urbanic J, Clark H, Petty WJ, Blackstock AW, et al. Long-Term Outcomes from a Phase 2 Trial of Radiofrequency Ablation Combined With External Beam Radiation Therapy for Patients With Inoperable Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 2021 Sep;111(1):152–6.
König L, Häfner MF, Katayama S, Koerber SA, Tonndorf-Martini E, Bernhardt D, et al. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients. Radiation Oncology. 2020 Feb 4;15(1)
Kapadia NS, Valle LF, George JA, Jagsi R, D’Amico TA, Dexter EU, et al. Patterns of Treatment and Outcomes for Definitive Therapy of Early Stage Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery. 2017 Dec;104(6):1881–8.
Zehentmayr F, Sprenger M, Rettenbacher L, Wass R, Porsch P, Fastner G, et al. Survival in early lung cancer patients treated with high dose radiotherapy is independent of pathological confirmation. Thoracic Cancer. 2019 Jan 7;10(2):321–9.
Palma DA, Nguyen TK, Louie AV, Malthaner R, Fortin D, Rodrigues GB, et al. Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non–Small Cell Lung Cancer. JAMA Oncology. 2019 May 1;5(5):681.
Assistência de Enfermagem ao Paciente com Câncer de Pulmão – Vital Knowledge. Available from: https://vitalknowledge.com.br/assistencia-de-enfermagem-ao-paciente-.
